Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10009167HBVENSG00000183873.20protein_codingSCN5ANoNo6331E9PG18
E9PHB6
H9KVD2
K4DIA1
Q14524
Q86V90
TVIS20012030HPVENSG00000183873.20protein_codingSCN5ANoNo6331E9PG18
E9PHB6
H9KVD2
K4DIA1
Q14524
Q86V90
TVIS20036049HPVENSG00000183873.20protein_codingSCN5ANoNo6331E9PG18
E9PHB6
H9KVD2
K4DIA1
Q14524
Q86V90
TVIS20056806HPVENSG00000183873.20protein_codingSCN5ANoNo6331E9PG18
E9PHB6
H9KVD2
K4DIA1
Q14524
Q86V90
TVIS44025067HTLV-1ENSG00000183873.20protein_codingSCN5ANoNo6331E9PG18
E9PHB6
H9KVD2
K4DIA1
Q14524
Q86V90
TCGA Plot Options
Drug Information
GeneSCN5A
DrugBank IDDB00527
Drug NameCinchocaine
Target IDBE0000197
UniProt IDQ14524
Regulation Typeinhibitor
PubMed IDs17139284; 17016423; 12354567; 9742684; 8798723; 11752352
CitationsOverington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.@@Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.@@Oka M, Itoh Y, Fujita T: Halothane attenuates the cerebroprotective action of several Na+ and Ca2+ channel blockers via reversal of their ion channel blockade. Eur J Pharmacol. 2002 Oct 4;452(2):175-81.@@Louro SR, Anteneodo C, Wajnberg E: Carboxyl groups at the membrane interface as molecular targets for local anesthetics. Biophys Chem. 1998 Aug 4;74(1):35-43.@@Ryan SE, Demers CN, Chew JP, Baenziger JE: Structural effects of neutral and anionic lipids on the nicotinic acetylcholine receptor. An infrared difference spectroscopy study. J Biol Chem. 1996 Oct 4;271(40):24590-7.@@Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.
GroupsApproved; Vet_approved
Direct ClassificationQuinolones and derivatives
SMILESCCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC
PathwaysDibucaine Action Pathway
PharmGKBPA449286
ChEMBLCHEMBL1086